Market Leadership Nordmark Pharma is a global leader in the manufacturing of biologically derived active ingredients such as Pankreatin and Kollagenase, presenting opportunities to collaborate on high-demand, specialized pharmaceutical ingredients.

Innovation Focus The company's expertise in developing and producing new active pharmaceutical ingredients lends itself to partnerships in research and development, particularly in the biotech and biologics sectors.

Expansion Through Partnerships Recent collaborations with Amsbio and VIVUS demonstrate Nordmark's active engagement in expanding its GMP-grade enzyme offerings, opening doors for joint ventures or supply agreements in advanced tissue dissociation and clinical applications.

Sustainability & Quality Nordmark emphasizes sustainable quality management, making it an attractive partner for customers seeking compliant, reliable manufacturing solutions aligned with regulatory standards.

Growth Potential With annual revenues estimated between $25 million and $50 million and a focus on niche biotechnological manufacturing, Nordmark displays robust growth prospects, ideal for companies targeting specialized pharmaceutical and biotech supply chains.